Citations

Clear

1053 citation(s) found for "Andre, F".

Tourette syndrome deep brain stimulation: A review and updated recommendations
Schrock, Lauren E. , Woods, Douglas W. , Porta, Mauro, Servello, Domenico , Silburn, Peter A., Walker, Harrison C. , Shahed‐Jimenez, Joohi, Savica, Rodolfo , Klassen, Bryan T. , Foote, Kelly D. , Ackermans, Linda , Temel, Yasin , Changizi, Barbara Kelly , Lozano, Andrés M. , Auyeung, M., Kaido, Takanobu, Agid, Yves, Welter, Marie Laure, Khandhar, Suketu M., Pourfar, Michael , Walter, Benjamin L. , Juncos, Jorge L., Leckman, James F. , Neimat, Joseph A, Okun, Michael S. , Jimenez‐Shahed, Joohi , Mink, Jonathan W. , Visser-Vandewalle, Veerle E. R. M. , Foltynie, Thomas , Machado, André G. , Zhang, Jianguo , Hu, Wei , Mari, Zoltan K. , Auyeung, Man , Mogilner, Alon Y. , Gross, Robert E. , Kuhn, Jens , Okun, Michael S , Leckman, James F , Walter, Benjamin L , Jimenez-Shahed, Joohi , Welter, Marie‐Laure

Mayo Clinic

Movement Disorders | December 8, 2014 | Volume: 30 | Issue: 4 | Pages: 448-471

10.1002/mds.26094 | PMID 25476818 Get It

Abstract Deep brain stimulation (DBS) may improve disabling tics in severely affected medication and behaviorally resistant Tourette syndrome (TS). Here we review all reported cases of TS DBS and provide updated recommendations for selection, assessment, and management of potential TS DBS cases based on the literature and implantation experience. Candidates should have a Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition (DSM V) diagnosis of TS with severe motor and vocal tics, which despite exhaustive medical and behavioral treatment trials result in significant impairment. Deep brain stimulation should be offered to patients only by experienced DBS centers after evaluation by a multidisciplinary team. Rigorous preoperative and postoperative outcome measures of tics and associated comorbidities should be used. Tics and comorbid neuropsychiatric conditions should be optimally treated per current expert standards, and tics should be the major cause of disability. Psychogenic tics, embellishment, and malingering should be recognized and addressed. We have removed the previously suggested 25‐year‐old age limit, with the specification that a multidisciplinary team approach for screening is employed. A local ethics committee or institutional review board should be consulted for consideration of cases involving persons younger than 18 years of age, as well as in cases with urgent indications. Tourette syndrome patients represent a unique and complex population, and studies reveal a higher risk for post‐DBS complications. Successes and failures have been reported for multiple brain targets; however, the optimal surgical approach remains unknown. Tourette syndrome DBS, though still evolving, is a promising approach for a subset of medication refractory and severely affected patients. © 2014 International Parkinson and Movement Disorder Society
Metabolic determinants of embryonic development and stem cell fate
Folmes, Clifford D.L. , Terzic, André , Folmes, Clifford D L

Mayo Clinic

Reproduction, Fertility and Development | December 3, 2014 | Volume: 27 | Issue: 1 | Pages: 82-88

10.1071/rd14383 | PMID 25472047 Get It

Decoding stem cell metabolism has implicated a tight linkage between energy metabolism and cell fate regulation, a dynamic interplay vital in the execution of developmental and differentiation programs. The inherent plasticity in energy metabolism enables prioritisation of metabolic pathways in support of stage-specific demands. Beyond traditional support of energetic needs, intermediate metabolism may also dictate cell fate choices through regulation of cellular signalling and epigenetic regulation of gene expression. The notion of a ‘metabolism-centric’ control of stem cell differentiation has been informed by developmental embryogenesis based upon an on-demand paradigm paramount in defining diverse developmental behaviours, from a post-fertilisation nascent zygote to complex organogenesis leading to adequate tissue formation and maturation. Monitored through natural or bioengineered stem cell surrogates, nutrient-responsive metabolites are identified as mediators of cross-talk between metabolic flux, cell signalling and epigenetic regulation charting, collectively, whether a cell will self-renew to maintain progenitor pools, lineage specify to ensure tissue (re)generation or remain quiescent to curb stress damage. Thus, bioenergetics are increasingly recognised as integral in governing stemness and associated organogenic decisions, paving the way for metabolism-defined targets in control of embryology, stem cell biology and tissue regeneration.
Biological Strategies for Improved Osseointegration and Osteoinduction of Porous Metal Orthopedic Implants
Lewallen, Eric A. , Riester, Scott M. , Kremers, Hilal Maradit , Dudakovic, Amel , Cohen, Robert C., Lewallen, David G. , Wijnen, André J. van , Lewallen, Eric Alexander, Bonin, Carolina A. , Kakar, Sanjeev , Westendorf, Jennifer J. , van Wijnen, Andre J , Maradit Kremers, Hilal

Mayo Clinic

Tissue Engineering Part B: Reviews | October 27, 2014 | Volume: 21 | Issue: 2 | Pages: 218-230

10.1089/ten.teb.2014.0333 | PMID 25348836 Get It

The biological interface between an orthopedic implant and the surrounding host tissue may have a dramatic effect upon clinical outcome. Desired effects include bony ingrowth (osseointegration), stimulation of osteogenesis (osteoinduction), increased vascularization, and improved mechanical stability. Implant loosening, fibrous encapsulation, corrosion, infection, and inflammation, as well as physical mismatch may have deleterious clinical effects. This is particularly true of implants used in the reconstruction of load-bearing synovial joints such as the knee, hip, and the shoulder. The surfaces of orthopedic implants have evolved from solid-smooth to roughened-coarse and most recently, to porous in an effort to create a three-dimensional architecture for bone apposition and osseointegration. Total joint surgeries are increasingly performed in younger individuals with a longer life expectancy, and therefore, the postimplantation lifespan of devices must increase commensurately. This review discusses advancements in biomaterials science and cell-based therapies that may further improve orthopedic success rates. We focus on material and biological properties of orthopedic implants fabricated from porous metal and highlight some relevant developments in stem-cell research. We posit that the ideal primary and revision orthopedic load-bearing metal implants are highly porous and may be chemically modified to induce stem cell growth and osteogenic differentiation, while minimizing inflammation and infection. We conclude that integration of new biological, chemical, and mechanical methods is likely to yield more effective strategies to control and modify the implant–bone interface and thereby improve long-term clinical outcomes.
Stem Cell in the Rough
Behfar, Atta , Terzic, André , Behfar, Atta

Mayo Clinic

Circulation Research | October 23, 2014 | Volume: 115 | Issue: 10 | Pages: 814-816

10.1161/circresaha.114.305075 | PMID 25342767 Get It

Planar Cell Polarity Aligns Osteoblast Division in Response to Substrate Strain
Galea, Gabriel L. , Meakin, Lee B. , Savery, Dawn, Taipaleenmäki, Hanna , Delisser, Peter , Copp, Andrew J. , Wijnen, André J. van , Lanyon, Lance E., Price, Joanna S., Stein, Gary S. , van Wijnen, Andre J

Mayo Clinic

Journal of Bone and Mineral Research | September 29, 2014 | Volume: 30 | Issue: 3 | Pages: 423-435

10.1002/jbmr.2377 | PMID 25264362 Get It

ABSTRACT Exposure of bone to dynamic strain increases the rate of division of osteoblasts and also influences the directional organization of the cellular and molecular structure of the bone tissue that they produce. Here, we report that brief exposure to dynamic substrate strain (sufficient to rapidly stimulate cell division) influences the orientation of osteoblastic cell division. The initial proliferative response to strain involves canonical Wnt signaling and can be blocked by sclerostin. However, the strain-related orientation of cell division is independently influenced through the noncanonical Wnt/planar cell polarity (PCP) pathway. Blockade of Rho-associated coiled kinase (ROCK), a component of the PCP pathway, prevents strain-related orientation of division in osteoblast-like Saos-2 cells. Heterozygous loop-tail mutation of the core PCP component van Gogh-like 2 (Vangl2) in mouse osteoblasts impairs the orientation of division in response to strain. Examination of bones from Vangl2 loop-tail heterozygous mice by µCT and scanning electron microscopy reveals altered bone architecture and disorganized bone-forming surfaces. Hence, in addition to the well-accepted role of PCP involvement in response to developmental cues during skeletal morphogenesis, our data reveal that this pathway also acts postnatally, in parallel with canonical Wnt signaling, to transduce biomechanical cues into skeletal adaptive responses. The simultaneous and independent actions of these two pathways appear to influence both the rate and orientation of osteoblast division, thus fine-tuning bone architecture to meet the structural demands of functional loading. © 2014 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.
iPS Cell–Derived Cardiogenicity is Hindered by Sustained Integration of Reprogramming Transgenes
Martinez‐Fernandez, Almudena , Reyes, Santiago , Alekseev, Alexey E., Secreto, Frank J., Pérez-Terzic, Carmen, Beraldi, Rosanna, Sung, Hoon‐Ki , Nagy, András , Secreto, Frank, Nelson, Timothy J. , Terzic, André

Mayo Clinic

Circulation: Cardiovascular Genetics | July 31, 2014 | Volume: 7 | Issue: 5 | Pages: 667-676

10.1161/circgenetics.113.000298 | PMID 25077947 Get It

Background—Nuclear reprogramming inculcates pluripotent capacity by which de novo tissue differentiation is enabled. Yet, introduction of ectopic reprogramming factors may desynchronize natural developmental schedules. This study aims to evaluate the effect of imposed transgene load on the cardiogenic competency of induced pluripotent stem (iPS) cells.Methods and Results—Targeted inclusion and exclusion of reprogramming transgenes (c-MYC,KLF4,OCT4, andSOX2) was achieved using a drug-inducible and removable cassette according to the piggyBac transposon/transposase system. Pulsed transgene overexpression, before iPS cell differentiation, hindered cardiogenic outcomes. Delayed in counterparts with maintained integrated transgenes, transgene removal enabled proficient differentiation of iPS cells into functional cardiac tissue. Transgene-free iPS cells generated reproducible beating activity with robust expression of cardiac α-actinin, connexin 43, myosin light chain 2a, α/β-myosin heavy chain, and troponin I. Although operational excitation–contraction coupling was demonstrable in the presence or absence of transgenes, factor-free derivatives exhibited an expedited maturing phenotype with canonical responsiveness to adrenergic stimulation.Conclusions—A disproportionate stemness load, caused by integrated transgenes, affects the cardiogenic competency of iPS cells. Offload of transgenes in engineered iPS cells ensures integrity of cardiac developmental programs, underscoring the value of nonintegrative nuclear reprogramming for derivation of competent cardiogenic regenerative biologics.
CBFβ and the Leukemogenic Fusion Protein CBFβ‐SMMHC Associate With Mitotic Chromosomes to Epigenetically Regulate Ribosomal Genes
López‐Camacho, César , Wijnen, André J. van , Lian, Jane B. , Stein, Janet L. , Stein, Gary S. , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Biochemistry | July 30, 2014 | Volume: 115 | Issue: 12 | Pages: 2155-2164

10.1002/jcb.24892 | PMID 25079347 Get It

ABSTRACTMitotic bookmarking is an epigenetic control mechanism that sustains gene expression in progeny cells; it is often found in genes related to the maintenance of cellular phenotype and growth control. RUNX transcription factors regulate a broad spectrum of RNA Polymerase (Pol II) transcribed genes important for lineage commitment but also regulate RNA Polymerase I (Pol I) driven ribosomal gene expression, thus coordinating control of cellular identity and proliferation. In this study, using fluorescence microscopy and biochemical approaches we show that the principal RUNX co‐factor, CBFβ, associates with nucleolar organizing regions (NORs) during mitosis to negatively regulate RUNX‐dependent ribosomal gene expression. Of clinical relevance, we establish for the first time that the leukemogenic fusion protein CBFβ‐SMMHC (smooth muscle myosin heavy chain) also associates with ribosomal genes in interphase chromatin and mitotic chromosomes to promote and epigenetically sustain regulation of ribosomal genes through RUNX factor interactions. Our results demonstrate that CBFβ contributes to the transcriptional regulation of ribosomal gene expression and provide further understanding of the epigenetic role of CBFβ‐SMMHC in proliferation and maintenance of the leukemic phenotype. J. Cell. Biochem. 115: 2155–2164, 2014. © 2014 Wiley Periodicals, Inc.
Inhibition of DNA Topoisomerase II Selectively Reduces the Threat of Tumorigenicity Following Induced Pluripotent Stem Cell-Based Myocardial Therapy
Wyles, Saranya P. , Oommen, Saji , Maleszewski, Joseph J. , Beraldi, Rosanna, Martinez‐Fernandez, Almudena , Yamada, Satsuki , Terzic, André , Nelson, Timothy J.

Mayo Clinic

Stem Cells and Development | July 18, 2014 | Volume: 23 | Issue: 19 | Pages: 2274-2282

10.1089/scd.2014.0259 | PMID 25036735 Get It

The advent of induced pluripotent stem cell (iPSC) technology creates new opportunities for transplant-based therapeutic strategies. The potential for clinical translation is currently hindered by the risk of dysregulated cell growth. Pluripotent stem cells reprogrammed by three-factor (Sox2, Klf, and Oct4) and four-factor (Sox2, Klf, Oct4, and c-Myc) strategies result in the capacity for teratogenic growth from residual pluripotent progeny upon in vivo transplantation. However, these pluripotent stem cells also have a stage-specific hypersensitivity to DNA-damaging agents that may allow separation of lineage-specific therapeutic subpopulation of cells. We aimed to demonstrate the selective effect of DNA topoisomerase II inhibitor, etoposide, in eliminating pluripotent cells in the early cardiac progenitor population thus decreasing the effect of teratoma formation. Immunodeficient murine hearts were infarcted and received implantation of a therapeutic dose of cardiac progenitors derived from partially differentiated iPSCs. Etoposide-treated cell implantation reduced mass formation in the intracardiac and extracardiac chest cavity compared with the same dose of iPSC-derived cardiac progenitors in the control untreated group. In vivo bioluminescence imaging confirmed the localization and engraftment of transplanted cells in the myocardium postinjection in both groups. Comparatively, the equivalent cell population without etoposide treatment demonstrated a greater incidence and size of teratoma formation. Hence, pretreatment with genotoxic etoposide significantly lowered the threat of teratogenicity by purging the contaminating pluripotent cells, establishing an adjunctive therapy to further harness the clinical value of iPSC-derived cardiac regeneration.
Metabolic Regulation of Redox Status in Stem Cells
Perales‐Clemente, Ester , Folmes, Clifford D.L. , Terzic, André , Folmes, Clifford D L

Mayo Clinic

Antioxidants & Redox Signaling | June 20, 2014 | Volume: 21 | Issue: 11 | Pages: 1648-1659

10.1089/ars.2014.6000 | PMID 24949895 Get It

Significance: Metabolism-dependent generation of reactive oxygen species (ROS) and associated oxidative damage have been traditionally linked to impaired homeostasis and cellular death. Beyond the adverse effects of ROS accumulation, increasing evidence implicates redox status as a regulator of vital cellular processes. Recent Advances: Emerging studies on the molecular mechanisms guiding stem cell fate decisions indicate a role for energy metabolism in regulating the fundamental ability of maintaining stemness versus undergoing lineage-specific differentiation. Stem cells have evolved protective metabolic phenotypes to minimize reactive oxygen generation through oxidative metabolism and support antioxidant scavenging through glycolysis and the pentose phosphate pathway. Critical Issues: While the dynamics in ROS generation has been correlated with stem cell function, the intimate mechanisms by which energy metabolism regulates ROS to impact cellular fate remain to be deciphered. Future Directions: Decoding the linkage between nutrient sensing, energy metabolism, and ROS in regulating cell fate decisions would offer a redox-dependent strategy to regulate stemness and lineage specification. Antioxid. Redox Signal . 21, 1648–1659.
Histone Deacetylase Inhibition Destabilizes the Multi‐Potent State of Uncommitted Adipose‐Derived Mesenchymal Stromal Cells
Dudakovic, Amel , Camilleri, Emily T. , Lewallen, Eric A. , McGee‐Lawrence, Meghan E. , Riester, Scott M. , Montecino, Martı́n , Stein, Gary S., Ryoo, Hyun‐Mo , Dietz, Allan B. , Wijnen, André J. van , Camilleri, Emily , Kakar, Sanjeev , Westendorf, Jennifer J. , van Wijnen, Andre J , Dietz, Allan B , McGee-Lawrence, Meghan E , Camilleri, Emily

Mayo Clinic

Journal of Cellular Physiology | June 9, 2014 | Volume: 230 | Issue: 1 | Pages: 52-62

10.1002/jcp.24680 | PMID 24912092 Get It

Human adipose‐derived mesenchymal stromal cells (AMSCs) grown in platelet lysate are promising agents for therapeutic tissue regeneration. Here, we investigated whether manipulation of epigenetic events by the clinically relevant histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alters differentiation of AMSCs. The multipotency of AMSCs was validated by their ability to differentiate into osteogenic, chondrogenic, and adipogenic lineages. High‐throughput RNA sequencing and RT‐qPCR established that human histone deacetylases (HDAC1 to HDAC11, and SIRT1 to SIRT7) are differentially expressed in AMSCs. SAHA induces hyper‐acetylation of histone H3 and H4, stimulates protein expression of the HDAC‐responsive gene SLC9A3R1/NHERF1 and modulates the AKT/FOXO1 pathway. Biologically, SAHA interferes with osteogenic, chondrogenic and adipogenic lineage commitment of multipotent AMSCs. Mechanistically, SAHA‐induced loss of differentiation potential of uncommitted AMSCs correlates with multiple changes in the expression of principal transcription factors that control mesenchymal or pluripotent states. We propose that SAHA destabilizes the multi‐potent epigenetic state of uncommitted human AMSCs by hyper‐acetylation and perturbation of key transcription factor pathways. Furthermore, AMSCs grown in platelet lysate may provide a useful biological model for screening of new HDAC inhibitors that control the biological fate of human mesenchymal stromal cells. J. Cell. Physiol. 230: 52–62, 2015. © 2014 Wiley Periodicals, Inc.